Výsledky vyhledávání - "Annie, Jouhaud"

Akademický článek

Effect of Serelys Homme on the Incidence and Severity of Vasomotor Symptoms and Quality-of-Life Impairments in Patients Receiving Hormone Therapy and Radiation for Localized Prostate Cancer: Results of the ESCULAPE Phase 2 Prospective Study

Autor: Yazid Belkacemi, MD, PhD, Gabriele Coraggio, MD, Anne Brunel, PhD, Annie Jouhaud, DM, Alexandre Ingels, MD, PhD, Charlotte Joly, MD, Asma Hadhri, MD, Wissal Hassani, MD, Gokoulakrichenane Loganadane, MD, Carolina Saldana, MD, PhD, Nabila Ouidir, MD, Barbara Vega, PhD, Kamel Debbi, MD, Alexandre de La Taille, MD, PhD

Publikováno v: Advances in Radiation Oncology, Vol 8, Iss 5, Pp 101255- (2023)

Purpose: Androgen deprivation therapy (ADT) may cause vasomotor symptoms (VMS) including hot flushes and sweats, which affect quality of life (QoL). Serelys Homme is a nonhormonal and a natural origin product that could affect VMS in men undergoing A

Externí odkaz: https://doaj.org/article/ee833dcd60964a2b8625b0355ab06172

Zobrazit plný text záznamu

Hemostatic radiotherapy for bladder cancer-related hematuria in patients unfit for surgery: is there any impact of fractionation schedule?

Autor: Gabriele, Coraggio, Shan, Husheng, Gokoulakrichenane, Loganadane, Sahar, Ghith, Noémie, Grellier, Marie Laure, Hervé, Nhu Hanh, To, Laurianne, Colson Durand, Annie, Jouhaud, Maryse, Fayolle Campana, Maya, Nourieh, Dimitri, Vordos, Yazid, Belkacemi

Publikováno v: Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 25(4)

The optimal schedule for palliative external beam radiotherapy (EBRT) in patients with bladder tumors with hematuria unfit for surgery remains undefined. This study aimed to assess the clinical hemostatic efficacy and safety of two EBRT hypofractiona

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ab0532e0a1843037113f9efd7b13075d
https://pubmed.ncbi.nlm.nih.gov/33099958

Zobrazit plný text záznamu

5FU/LV with or without irinotecan in patients with resected stage II-III rectal cancer: Final analysis of R98 intergroup study

Autor: Olivier Dupuis, Roger Faroux, Annie Jouhaud, E. Quinaux, Marc Ychou, Pascal Piedbois, Céline Lepère, Veronique Guerin-Meyer, Jean-Yves Douillard, Catherine Delbaldo, Thierry André, Ayman Zawadi

Publikováno v: Journal of Clinical Oncology. 31:3542-3542

3542 Background: The goal of the study was to test whether adding Irinotecan to a 5-FU/LV adjuvant regimen improves disease free survival (DFS) or overall survival (OS) in optimally resected stages II-III rectal cancers. Primary end-point was DFS. Me

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0b793085825169e872292361cf2c1ea2
https://doi.org/10.1200/jco.2013.31.15_suppl.3542

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání